v3.26.1
Summary of Significant Accounting Policies (Details Narrative)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
Integer
Segment
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Product Information [Line Items]      
Reclassified from contingent consideration   $ 650  
Restricted cash $ 10,197 10,239  
Accounts receivable balance, net of allowance for credit losses $ 4,653 13,557 $ 10,046
Operating segments | Segment 3    
Advertising and marketing costs $ 24 23  
Instrument-specific credit risk income $ 5    
Instrument-specific credit risk loss   $ 5  
Income tax examination likelihood settlement The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority.    
Number of segments | Integer 3    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]      
Product Information [Line Items]      
Concentration risk, percentage 37.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers [Member]      
Product Information [Line Items]      
Concentration risk, percentage   46.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]      
Product Information [Line Items]      
Concentration risk, percentage 21.00% 17.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]      
Product Information [Line Items]      
Concentration risk, percentage 12.00% 16.00%  
Minimum [Member]      
Product Information [Line Items]      
Contracted storage periods 18 years    
Over time for a period 1 month    
Maximum [Member]      
Product Information [Line Items]      
Contracted storage periods 25 years    
Over time for a period 24 months    
Cell Therapy [Member]      
Product Information [Line Items]      
Goodwill impairment $ 0 $ 0  
Letter of Credit [Member]      
Product Information [Line Items]      
Restricted cash $ 10,197 $ 10,239